retatrutide type 2 diabetes trial 2024 This data from Phase 3 clinical trials for was announced yesterday at @amdiabetesassn #ADA2026 ✓ We are fortunate to be living in a time where there multiple medications which safely reduce Retatrutide Dosing Guide: 1-12 mg

Room temperature solution is more comfortable than cold solution, so let the syringe warm in your hand for 30 seconds after drawing the dose (but do not leave the vial out of the fridge)

July 9, 2025: Some Ozempic Vision Loss Lawsuits May Be Consolidated in New Jersey Some Ozempic and Wegovy users have experienced serious vision damage and even lost their sight after taking these medications

Retatrutide remains an active area of scientific investigation

A significant number of Phase 2 participants achieved clinically meaningful weight loss at 4mg and 8mg

Approved GLP-1-based therapies can still have side effects, contraindications, and monitoring needs